Stefanie Heynck

5.0k total citations
6 papers, 418 citations indexed

About

Stefanie Heynck is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stefanie Heynck has authored 6 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Organic Chemistry, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stefanie Heynck's work include Lung Cancer Treatments and Mutations (3 papers), Cancer therapeutics and mechanisms (2 papers) and Synthesis and biological activity (2 papers). Stefanie Heynck is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Cancer therapeutics and mechanisms (2 papers) and Synthesis and biological activity (2 papers). Stefanie Heynck collaborates with scholars based in Germany, United States and South Africa. Stefanie Heynck's co-authors include Martin L. Sos, Daniel Rauh, Roman K. Thomas, Martin Peifer, Mirjam Koker, Jonathan M. Weiss, Johannes M. Heuckmann, Haridas B. Rode, Matthias Rabiller and Christian Grütter and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Stefanie Heynck

6 papers receiving 411 citations

Peers

Stefanie Heynck

PRM

ONCOL

MB

OC

CR

Bo Hee Shin United States

Julia Ketzer Germany

Masaya Nishino Japan

Donna-Michelle Smith United Kingdom

Sebastian H. B. Kroll United Kingdom

Shigenari Nukaga Japan

Chee-Seng Tan Singapore

Toshiya Ito Japan

Xiao-E Yan China

Cath Trigwell United Kingdom

Bo Hee Shin United States

Stefanie Heynck

265 ×0.9

PRM

259 ×1.0

ONCOL

344 ×1.5

MB

95 ×1.0

OC

24 ×0.5

CR

Citations per year, relative to Stefanie Heynck Stefanie Heynck (= 1×) peers Bo Hee Shin

Countries citing papers authored by Stefanie Heynck

Since Specialization

Citations

This map shows the geographic impact of Stefanie Heynck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Heynck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Heynck more than expected).

Fields of papers citing papers by Stefanie Heynck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Heynck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Heynck. The network helps show where Stefanie Heynck may publish in the future.

Co-authorship network of co-authors of Stefanie Heynck

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Heynck. A scholar is included among the top collaborators of Stefanie Heynck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Heynck. Stefanie Heynck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Richters, André, Julia Ketzer, Matthäus Getlik, et al.. (2013). Targeting Gain of Function and Resistance Mutations in Abl and KIT by Hybrid Compound Design. Journal of Medicinal Chemistry. 56(14). 5757–5772. 11 indexed citations

2.

Heuckmann, Johannes M., Michael Hölzel, Martin L. Sos, et al.. (2011). ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors. Clinical Cancer Research. 17(23). 7394–7401. 147 indexed citations

3.

Sos, Martin L., Haridas B. Rode, Stefanie Heynck, et al.. (2010). Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation. Cancer Research. 70(3). 868–874. 175 indexed citations

4.

Rode, Haridas B., Martin L. Sos, Christian Grütter, et al.. (2010). Synthesis and biological evaluation of 7-substituted-1-(3-bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptor. Bioorganic & Medicinal Chemistry. 19(1). 429–439. 9 indexed citations

5.

Peifer, Martin, Jonathan M. Weiss, Martin L. Sos, et al.. (2010). Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling. PLoS ONE. 5(1). e8919–e8919. 22 indexed citations

6.

Sos, Martin L., Haridas B. Rode, Matthias Rabiller, et al.. (2010). Synthesis and Biological Evaluation of 4-Anilinoquinolines as Potent Inhibitors of Epidermal Growth Factor Receptor. Journal of Medicinal Chemistry. 53(7). 2892–2901. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact